Why are methods based on neuroplasticity, such as FaceFormer® therapy, not more widespread?

Question

A question we often receive is: “If neuroplasticity is accepted in neuroscience, why are therapeutic approaches based on it, such as FaceFormer therapy, not more widely available and established?”

Answer

The answer to this question is complex. On the one hand, it should be noted that new therapeutic approaches such as FaceFormer therapy need time to establish themselves in the mainstream of clinical practice. It is a natural process that innovative methods are not immediately universally accepted, even though they are modern and progressive.

On another level, the acceptance of neuroplasticity – and therapies that utilize it, such as FaceFormer therapy – symbolizes a profound shift in our fundamental understanding of how the brain works. The concept of a ‘neuroplastic brain’ challenges traditional models of medicine, which is naturally met with resistance. Overcoming this resistance is a process that requires time, perseverance and persuasion.

However, it is important to emphasize that the benefits and effectiveness of FaceFormer therapy have also been proven by numerous studies. With time and further research, it is expected that therapies based on neuroplasticity will become increasingly mainstream in clinical practice. In the meantime, we strive to disseminate these important findings and educate physicians, therapists and patients about the benefits of FaceFormer therapy.